Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
News
Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Aruna Bio to Participate in the BIO Investor Forum in October 2023
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
Aruna Bio to Participate in the BIO Investor Forum in October 2023
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…
Rhythm Pharmaceuticals Announces Six Abstracts to be Presented at The Obesity Society’s Annual Meeting at ObesityWeek ®
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Rhythm Pharmaceuticals Announces Six Abstracts to be Presented at The Obesity Society’s Annual Meeting at ObesityWeek ®
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
MADISON, Wis., Oct. 10, 2023 (GLOBE NEWSWIRE) — Stem Pharm, Inc., a drug discovery platform…
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
MADISON, Wis., Oct. 10, 2023 (GLOBE NEWSWIRE) — Stem Pharm, Inc., a drug discovery platform…
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
— Enhances diversity and expertise in key areas including scientific, commercial, and financial — TAMPA,…
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
— Enhances diversity and expertise in key areas including scientific, commercial, and financial — TAMPA,…
Taysha Gene Therapies Announces Two Poster Presentations on TSHA-102 in Rett Syndrome at Upcoming European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
DALLAS, Oct. 10, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage…
Taysha Gene Therapies Announces Two Poster Presentations on TSHA-102 in Rett Syndrome at Upcoming European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
DALLAS, Oct. 10, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage…
ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
At the 36th European College of Neuropsychopharmacology congress (ECNP-2023) MADRID, Spain and BOSTON, Oct. 10,…
ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
At the 36th European College of Neuropsychopharmacology congress (ECNP-2023) MADRID, Spain and BOSTON, Oct. 10,…